PlainPharmaWatch
CMS PY 2024 Company profile Open Payments data

BECTON, DICKINSON AND COMPANY

BECTON, DICKINSON AND COMPANY reported $17.8M in payments to physicians and teaching hospitals across 12,741 transactions in CMS Open Payments PY 2024.

Pharmaceutical payment transparency data for BECTON, DICKINSON AND COMPANY. Ranked #97 of 1,797 companies by total payments. Source: CMS Open Payments, Program Year 2024.

Payment Overview

Total Payments

$17.8M

0.1% of all payments

Transactions

12,741

$1.4K avg

Recipients

12,581

$1.4K avg

Industry Rank

#97

of 1,797 companies

What the Data Shows for BECTON, DICKINSON AND COMPANY

In Program Year 2024, BECTON, DICKINSON AND COMPANY reported $17,791,035.06 in payments to 12,581 physicians and teaching hospitals across 12,741 individual transactions — an average of $1.4K per transaction and $1.4K per recipient. That total places BECTON, DICKINSON AND COMPANY at rank #97 out of 1,797 companies in the CMS Open Payments database, representing 0.1% of all industry payments reported nationwide for the year. Payment volume at this scale is characteristic of manufacturers with broad prescriber engagement, active clinical research programs, or patented therapies generating ongoing royalty obligations.

The payment mix for BECTON, DICKINSON AND COMPANY spans 13 distinct categories defined by CMS — including general payments (consulting, speaker fees, meals, travel), research payments tied to clinical trials, and ownership or investment interests. The largest single category is "Debt Forgiveness" at $4.8M, accounting for 27.2% of the company's reported total and 50 transactions. This distribution matters because different payment types carry different regulatory and ethical implications: research funding supports clinical development, while general payments like meals and speaker fees have been studied for their correlation with prescribing patterns in peer-reviewed journals such as JAMA Internal Medicine.

Recipient concentration is another useful lens. The top 5 recipients of payments from BECTON, DICKINSON AND COMPANY received $0.00 combined — 0.0% of the company's total — with the remaining 100.0% distributed across the rest of the 12,581 recipients. A relatively distributed top-5 share suggests broader engagement across the prescriber community rather than concentration among a handful of high-value relationships. All figures above are drawn directly from the CMS Open Payments Public Use Files for PY2024 and are disclosed under the Physician Payments Sunshine Act; this page summarizes reported financial transfers and does not represent medical advice or judgment about individual prescribing decisions.

Payment Breakdown by Type

BECTON, DICKINSON AND COMPANY made 13 types of payments. "Debt Forgiveness" accounts for 27.2%.

Debt Forgiveness $4.8M

27.2% · 50 transactions

Royalty or License $912.0K

5.1% · 315 transactions

Consulting Fee $626.3K

3.5% · 444 transactions

Food and Beverage $491.9K

2.8% · 9,873 transactions

Travel and Lodging $356.4K

2.0% · 1,052 transactions

Compensation for Services Other Than Consulting $255.1K

1.4% · 679 transactions

Long-Term Medical Supply or Device Loan $172.0K

1.0% · 28 transactions

Honoraria $48.2K

0.3% · 33 transactions

Payment Type Amount Transactions
Debt Forgiveness $4.8M 50
Royalty or License $912.0K 315
Consulting Fee $626.3K 444
Food and Beverage $491.9K 9,873
Travel and Lodging $356.4K 1,052
Compensation for Services Other Than Consulting $255.1K 679
Long-Term Medical Supply or Device Loan $172.0K 28
Honoraria $48.2K 33
Education $35.0K 85
Grant $15.0K 5
Charitable Contribution $6.4K 11
Space Rental or Facility Fees $4.0K 4
Gift $139.00 2

Payment Size Analysis

Average transaction size: $1.4K. Average per recipient: $1.4K.

Total Amount

$17,791,035.06

Avg per Transaction

$1.4K

Avg per Recipient

$1.4K

Payment Transparency Context

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.3B

across 1,797 companies

BECTON, DICKINSON AND COMPANY Share

0.1%

#97 by total payments

Frequently Asked Questions

How much did BECTON, DICKINSON AND COMPANY pay to physicians and hospitals in 2024?
BECTON, DICKINSON AND COMPANY made $17,791,035.06 in payments to physicians and hospitals in Program Year 2024, across 12,741 individual transactions. This represents 0.1% of all industry payments reported to CMS Open Payments.
How many physicians received payments from BECTON, DICKINSON AND COMPANY?
BECTON, DICKINSON AND COMPANY made payments to 12,581 physicians and teaching hospitals in 2024. The average payment per recipient was $1.4K.
What types of payments did BECTON, DICKINSON AND COMPANY make?
BECTON, DICKINSON AND COMPANY made 13 different types of payments. The largest category was "Debt Forgiveness" at $4.8M, representing 27.2% of all payments.
How does BECTON, DICKINSON AND COMPANY rank among pharmaceutical companies?
BECTON, DICKINSON AND COMPANY ranks #97 out of 1,797 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from BECTON, DICKINSON AND COMPANY?
The average transaction from BECTON, DICKINSON AND COMPANY was $1.4K in 2024. The company made 12,741 total transactions to 12,581 recipients.
Are the top recipients concentrated for BECTON, DICKINSON AND COMPANY?
The top 5 recipients received $0.00 from BECTON, DICKINSON AND COMPANY, representing 0.0% of the company's total payments. Payments are relatively well-distributed across recipients.
Where does the payment data for BECTON, DICKINSON AND COMPANY come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.3B across 1,797 companies.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.